Skip to main content(Press Enter).
The COVID-19 Coronavirus health crisis is presenting unprecedented challenges that are being felt worldwide and deep in the heart of our communities. At Combined Insurance, we have taken steps to protect our employees and their families while working to maintain solid levels of support and service for our customers
Start of main content
Alli Walsh, Social Media Strategist
More than five million Americans are living with Alzheimer’s disease in 2017 and according the Alzheimer’s Association, that number could rise to 16 million by 2050.1 The disease kills more people than prostate cancer and breast cancer combined2, and the devastating effects ripple out, impacting loved ones near and far. Currently, there is no cure for Alzheimer’s disease. Supplementally Speaking is highlighting three current areas of research and sharing renewed hope for those with the disease.
While much past research related to new Alzheimer’s treatments has been focused on commonly seen amaloid-beta deposits in the brain, scientists struggle to gain traction with drugs focused on this area.3 While testing shows decrease in the deposits, it does not demonstrate reduced symptoms. Many researchers are turning their attention toward brain inflammation –another trademark of the disease—as a cause instead of being only a byproduct.4 Studies in mice show promise in drugs designed to target immune cells called microglia, which tend to be overactive in Alzheimer’s patients. Initial results demonstrated reduced memory and behavioral problems and also prevented brain cell communication errors commonly seen in Alzheimer’s patients.5
Epigenetics, simply defined, is the study of biological mechanisms that will switch genes on and off. Epigenetics affect how genes are interpreted by bodily cells and in turn, how those cells react.6 Understanding how certain genes are turned on and off and all possible on/off combinations could, in theory, determine cures for many diseases and ailments.7 Epigenetic alterations have been identified in Alzheimer’s disease, and more research is being conducted to further understanding and therapeutic applications.8
Twenty-five years ago, a diagnosis of HIV meant certain death, but today, thanks to pharmaceutical advances and combination therapy, those diagnosed can go on to live long lives.9 This same story has played out in relation to cancer and heart disease and in recent years, the probability of treating Alzheimer’s disease similarly has become popular. Thanks to a joint effort called the Alzheimer's Combination Therapy Opportunities grant initiative, $2 million will be provided in 2017 for analyzing combination therapies that target two or more processes believed to be related to Alzheimer’s disease. The combination approach may utilize drugs currently approved to treat other conditions, which could limit time-to-market for approved combinations.10
References: 1,2 “Latest Alzheimer's Facts and Figures.” Latest Facts & Figures Report | Alzheimer's Association, Alzheimer's Association. 3 “Alzheimer's Disease and Inflammation: Pritam Das.” Mayo Clinic, Mayo Foundation for Medical Education and Research. 4,5 “Blocking Brain Inflammation 'Halts Alzheimer's Disease'.” BBC News, BBC, 8 Jan. 2016. 6 “A Super Brief and Basic Explanation of Epigenetics for Total Beginners.” What Is Epigenetics?, What Is Epigenetics?, 17 Oct. 2017. 7, 8 Semedo, PhD Daniela. “Alzheimer's Review Highlights Importance of Epigenetic Changes.” Alzheimer's News Today, BioNews Services, LLC, 7 Jan. 2016. 9, 10 Hendrix, James. “A New Approach to Alzheimer's.” Scientific American Blog Network, Scientific American, 23 May 2017.
Summer Fun with Fruit: Diabetes-Friendly Desserts
10 of the Biggest Mistakes People Make when Getting (back) into Working Out
The Science Behind HIIT
Get protection from the hidden costs of accidents, illnesses and income disruption.
Offer your employees additional benefits with no extra cost to your company.
Learn more about our leadership, our vision and what we're doing.
“Start of statement by W. CLEMENT STONE, FOUNDERDo the right thing because it's the right thing to do.End of statement ”W. CLEMENT STONE, FOUNDER
Combined Insurance Company of America (Chicago, IL Illinois) is a leading provider of individual supplemental accident, disability, health, and life insurance products and a Chubb company. With a tradition of nearly 100 years of success, we have an A+ rating by the Better Business Bureau and are one of Ward’s Top 50® Performing Life-Health Insurance Companies. Combined Insurance is also the number one Military Friendly® Employer in the over $1B revenue category for 2019 by VIQTORY. This is the company’s eighth consecutive year on the top 10 list and fifth consecutive year in the top 5—Combined Insurance was previously named the number one Military Friendly® Employer in the nation for 2015 and 2016. In New York, products are underwritten by Combined Life Insurance Company of New York (Latham, NY).
Products & Solutions
© 2020 Combined Insurance. All rights reserved.